Results 121 to 130 of about 1,404,808 (156)

Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre Study. [PDF]

Int J Mol Sci
Zannoni GF, Angelico G, d'Amati A, D'Alessandris N, Scaglione G, Urtueta BP, Ferrara G, Caliò A, Campisi P, De Leo A, Guerini Rocco E, Iuzzolino M, Lerda L, Paolini B, Punzi A, Vinci M, Troncone G, Santoro A.   +17 more
europepmc   +1 more source

Active Targeting of Colorectal Cancer Using Chemotherapy-Loaded Nanoparticles Functionalized with a Folate Receptor-α (FRα) Ligand, Pemetrexed. [PDF]

Pharm Res
Alnatour M, Sen R, Janardhanam LSL, Anjum MM, Geary SM, Salem AK.   +5 more
europepmc   +1 more source

Folate Receptor Alpha Targeted Immuno-Positron Emission Tomography Probe for Noninvasive Imaging in Triple-Negative Breast Cancer. [PDF]

Chem Biomed Imaging
Ma X, Yang N, Guo X, Liu J, Zhang Y, Zhu H, Liu Y, Yang Z.   +7 more
europepmc   +1 more source

Widespread folate receptor expression in pediatric and adolescent solid tumors - opportunity for intraoperative visualization with the novel fluorescent agent pafolacianine. [PDF]

Oncotarget
Dodd AC, Wadhwani NR, Lehane A, Brown R, MacQuarrie KL, Goldstein SD, Lautz TB.   +6 more
europepmc   +1 more source

Folate Receptor Alpha-A Secret Weapon in Ovarian Cancer Treatment? [PDF]

Int J Mol Sci
Bukowski K, Rogalska A, Marczak A.
europepmc   +1 more source

A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer. [PDF]

Clin Cancer Res
Knutson KL, Abu-Fares H, Keating P, Block MS, Norton N, Erskine CL, Cogen D, Assad H, Graff SL, Hamilton EP, Han HS, McIntyre KJ, Nassar A, Sparano JA, Tiersten A, Tkaczuk KH, Ward PJ, Wilson G, Garrett G, Kenney RT, Sharma P.   +20 more
europepmc   +1 more source

Statement of Retraction: Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein. [PDF]

Bioengineered
europepmc   +1 more source

Novel fully human IgG1 targeting folate receptor α demonstrates antitumor efficacy driven by avidity rather than monovalent binding affinity. [PDF]

Sci Rep
Pinto E, Tresoldi D, Arlotta V, Luison E, Frigerio B, Corsiero E, Raspagliesi F, Karagiannis SN, Canevari S, Mezzanzanica D, Figini M.   +10 more
europepmc   +1 more source

Real-world insights into the prevalence and prognostic significance of trophoblast cell-surface antigen 2 and folate receptor alpha in uterine carcinosarcoma. [PDF]

BMC Cancer
de Albuquerque LZ, da Silva JL, Rodrigues FR, Fernandes PV, Small IÁ, Leite LF, Guitmann G, de Melo AC.   +7 more
europepmc   +1 more source